University of Wisconsin–Madison

(TCAD) A Phase 2 Multi-center, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients with Mild to Moderate Alzheimer’s Disease

August 2014 to April 2016

This project led by: Sanjay Asthana, MD